Research Article

A Randomized Controlled Trial of Chuanhutongfeng Mixture for the Treatment of Chronic Gouty Arthritis by Regulating miRNAs

Table 3

Baseline information of patients in the 3 groups.

IndicatorsControl group
(n = 52)
Allopurinol group
(n = 55)
Chuanhutongfeng mixture group (n = 58)P-value

Age49.90 ± 9.0050.50 ± 8.9051.10 ± 9.100.784
Gender (% of males)50 (96.15)53 (96.36)55 (94.83)0.908
BMI (kg/m2)25.33 ± 1.1225.46 ± 1.0625.50 ± 1.260.726
Systolic pressure (mmHg)133.00 ± 7.00132.00 ± 8.00134.00 ± 7.000.354
Diastolic pressure (mmHg)76.00 ± 5.0075.00 ± 7.0075.00 ± 6.000.618
Disease duration (years)9.90 ± 5.119.91 ± 5.429.87 ± 5.500.999
Tophus (n, %)26 (50.00)28 (50.91)30 (51.72)0.984
FBG (mmol/L)5.12 ± 0.585.21 ± 0.465.17 ± 0.630.710
TC (mmol/L)4.89 ±0.455.03 ± 0.465.10 ± 0.470.057
TG (mmol/L)2.17 ± 0.852.21 ± 0.722.16 ± 0.810.940
ALT (U/L)30.20 ± 9.5029.50 ± 8.8031.70 ± 8.400.406
AST (U/L)25.10 ± 7.7024.80 ± 7.4027.90 ± 8.500.074
eGFR(ml/min/1.73m2)110.10 ± 7.40111.50 ± 7.50110.40 ± 7.700.339
SUA (μmol/L)532.00 ± 69.00529.00 ± 72.00530.00 ± 74.000.976
ESR (mm/h)31.00 ± 14.2033.90 ± 15.7032.20 ± 16.300.622
CRP (mg/L)21.30 ± 9.2020.40 ± 10.8022.00 ± 12.100.734
Pain score3.54 ± 1.573.71 ±1.583.64 ±1.380.843
Swelling score1.97 ± 0.891.97 ± 0.951.97 ± 0.881.000
Restricted movement score1.98 ± 0.721.98 ± 0.891.99± 0.880.997
CCL2 (pg/mL)538.00 ± 223.00545.00 ± 175.00572.00 ± 160.000.597
CXCL8 (pg/mL)619.00 ± 199.00643.00 ± 181.00645.00 ± 218.000.757
miR-486-5p2.51 ± 1.222.31 ± 1.192.24 ± 1.310.505
miR-339-5p4.90 ± 1.984.93 ± 2.164.64 ± 2.180.725
miR-361-5p3.27 ± 1.803.15 ± 1.772.98 ± 1.470.661

BMI: body mass index; FBG: Fasting blood-glucose; TC: Total cholesterol; TG: triglyceride; ALT: alanine aminotransferase; AST: aspartate aminotransferase; eGFR: estimate glomerular filtration rate; SUA: serum uric acid; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; CCL2: chemokine (C-C motif) ligand 2; CXCL8: chemokine (C-X-C motif) ligand 8.